3.805
price down icon0.97%   -0.035
 
loading

Finanzdaten der Chimerix Inc-Aktie (CMRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.004 0.011 0.026 0.283
Operating Expenses
17.18%
24.39
20.81 26.70 21.37 24.50
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
17.20%
-24.39
-20.81 -26.69 -21.35 -24.22
Net Interest Income/Expense
4.83%
2.521
2.649 2.703 2.772 2.846
Interest Income/Expense After Provision For Losses
4.83%
2.521
2.649 2.703 2.772 2.846
Income/Loss From Continuing Operations Before Tax
20.42%
-21.87
-18.16 -23.99 -18.58 -21.37
Income/Loss From Continuing Operations After Tax
20.42%
-21.87
-18.16 -23.99 -18.58 -21.37
Net Income/Loss
20.42%
-21.87
-18.16 -23.99 -18.58 -21.37
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
86,380%
89.26
0.1032 88.62 88.58 88.29
Diluted Average Shares
86,380%
89.26
0.1032 88.62 88.58 88.29
Basic Earnings Per Share
19.05%
-0.25
-0.21 -0.27 -0.21 -0.24
Diluted Earnings Per Share
19.05%
-0.25
-0.21 -0.27 -0.21 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.30
price down icon 1.48%
$38.91
price up icon 8.49%
$371.83
price up icon 1.17%
$23.12
price up icon 4.50%
biotechnology ONC
$216.22
price down icon 1.00%
$115.51
price down icon 1.48%
Kapitalisierung:     |  Volumen (24h):